• Fact Checked
  • August 26, 2025
  • 11 min read

What Are Vaginal Community State Types (CSTs)?

Table of Contents
  1. 1. What Are CSTs?
  2. 2. A Quick Overview of Vaginal CSTs
  3. 3. The Five CSTs In Detail
  4. 4. Common Myths About Vaginal Community State Types (CSTs)
  5. 5. How to Find Out Your CST: Step-by-Step
  6. 6. Personalized Recommendations Based on Your CST
  7. 7. How Happy V Probiotics Can Help
  8. 8. When Should You See a Healthcare Provider?
  9. 9. Final Thoughts

Key Takeaways

  • Your vaginal microbiome plays a major role in everything from odor to infection risk, and most women fall into one of five "Community State Types" (CSTs).
  • CSTs are categorized by the dominant bacterial species in your vaginal microbiota. Some offer stronger protection than others.
  • While CSTs naturally shift over time, probiotics with clinically studied Lactobacillus strains may help support a balanced microbiome and a healthy vaginal environment.

Your vaginal microbiome plays a big role in how you feel every day1. This community of microorganisms, including vaginal lactobacilli and other pathogens, helps protect you from unusual discharge and odor and supports immune function.

Most vaginal microbiomes fall into one of five scientifically defined profiles called Community State Types (CSTs)2. Knowing your CST gives you powerful insight into your vaginal health, like whether you're more prone to bacterial vaginosis, how your body responds to hormonal shifts, and how best to support your vaginal microbiology over time.

This post is for informational purposes only and does not constitute medical advice. See full disclaimer below.

What Are CSTs?

CST stands for Community State Type, a system that groups vaginal microbiomes based on which bacterial species are most dominant3. While the vaginal microbiome can include thousands of bacterial strains in varying amounts, CST classification simplifies this into five main profiles. This helps make complex microbiome data easier to understand, track over time, and use in both care and research.

In clinical settings, CSTs can help support diagnoses like bacterial vaginosis (BV) or aerobic vaginitis, guide treatments such as probiotic or antibiotic use, and monitor shifts across key life stages, like pregnancy, menstruation, and menopause4.

For example, CST I (dominated by Lactobacillus crispatus) is associated with a low vaginal pH and strong protection5, while CST IV (rich in anaerobic bacteria like Gardnerella vaginalis) is linked to higher rates of BV, inflammation, and STI risk.

In research and real-world care, CSTs are also used to study conditions like recurrent yeast infections, preterm birth, hormonal shifts, and to build predictive models for infection and fertility risks.

Basically, by organizing complex bacterial communities into actionable categories, CSTs help bridge the gap between microbiome science and everyday women’s health decisions.

A Quick Overview of Vaginal CSTs

Like we mentioned, there are 5 main vaginal CSTs, each defined by the general microbial composition of the vaginal microbiome6. Different CST types are more common than others, and some are more protective than others, especially when it comes to BV and STI risk.

CST Dominant Bacteria pH Range Prevalence/ Commonality Key Health Notes
I L. crispatus ≤ 4.5 ~20% Most protective; low BV/STI risk
II L. gasseri 4.5–5.5 Less common Protective, slightly less stable
III L. iners Variable Common Transitional, more prone to dysbiosis
IV Mixed anaerobes >4.5 30–40%+ Higher BV risk, inflammation, high diversity
V L. jensenii ≤ 4.5 <10% Rare but highly protective

 

The Five CSTs In Detail

The above chart is helpful to compare the 5 CSTs at a glance and understand which CSTs are protective and which aren’t, but let’s also take a minute to discuss each of the CSTs in detail to fully understand their impact on your vaginal health.

CST I: Dominated by Lactobacillus crispatus

CST I is basically your vaginal microbiome’s overachiever. Dominated by L. crispatus, this CST produces both L- and D-lactic acid7, creating an acidic environment that wards off unwanted bacterial species like Gardnerella vaginalis

CST I is linked to lower risks of bacterial vaginosis (BV)8, yeast infections9, STIs10, and even preterm birth11. Unsurprisingly, this is one of the most desirable CSTs for overall vaginal health12.

CST II: Dominated by Lactobacillus gasseri

CST II is led by L. gasseri, another lactic acid producer13. While not as robust as L. crispatus, this CST still supports a healthy vaginal pH and helps keep dysbiosis (aka an imbalance of infection-causing bacteria) at bay14.

It’s not as common as CST I, but it’s generally associated with a resilient vaginal microbiota.

CST III: Dominated by Lactobacillus iners

Now here’s where things get a bit complicated. L. iners is a bit of a wildcard. It can be part of a healthy microbiome, but it's also found in transitional or unstable states, especially post-antibiotics or during hormonal shifts15.

CST III produces only L-lactic acid and lacks other antimicrobial compounds, making it less protective overall. It’s also been associated with persistent HPV infections and bacterial vaginosis.

CST IV: Mixed Anaerobes and High Diversity

CST IV is the most diverse—and the most misunderstood. This community lacks dominant Lactobacillus spp. and instead includes anaerobic species like Gardnerella vaginalis, Atopobium vaginae, Prevotella, and Megasphaera16

CST IV has been linked to higher vaginal pH, inflammation, and increased susceptibility to infections like BV and vaginitis.

But here’s the nuance: not all CST IV profiles are problematic17. Some contain Bifidobacterium, a more protective bacterial species. And while CST IV is more common in certain racial and ethnic groups (especially Black and Hispanic women)18, that doesn’t automatically equate to poor health. Context is everything.

CST IV Subtypes

Unlike other CSTs, CST IV contains many subtypes, including:

  • IV-A: Dominated by BVAB-1 and G. vaginalis
  • IV-B: High A. vaginae and G. vaginalis; often with biofilm-forming bacteria
  • IV-C0: Highly diverse with Prevotella
  • IV-C1: Dominated by Streptococcus; may be relevant in pregnancy
  • IV-C2: Enterococcus-dominated; linked to aerobic vaginitis and UTIs
  • IV-C3: Bifidobacterium-dominated; may be more stabilizing
  • IV-C4: Staphylococcus-dominated; often linked to inflammation

CST V: Dominated by Lactobacillus jensenii

CST V may be rare, but it’s mighty. L. jensenii is a powerful protector, producing D-lactic acid and natural antimicrobials19.

Though less common in cross-sectional datasets, CST V has been associated with vaginal stability and lower infection risk in women’s health research.

Common Myths About Vaginal Community State Types (CSTs)

There’s a lot of confusion out there about what your CST means and what it doesn’t. Let’s clear up a few of the most common myths so you can better understand your vaginal microbiome and how to support it.

Myth 1: “All bacteria in the vagina are harmful.”

Fact: The majority of bacteria in a healthy vagina are beneficial, especially Lactobacillus species. These microbes help maintain a low pH and protect against infections20.

Myth 2: “If you don’t have vaginal symptoms, your CST doesn’t matter.”

Fact: While many women with less protective CSTs (like CST IV) don’t experience uncomfortable itching or odor, these microbiome types can still increase the risk of future issues, such as bacterial vaginosis, STIs, or complications in pregnancy. Regular monitoring is wise, even if you feel fine21.

Myth 3: “Douching or using special cleansers will improve your CST.”

Fact: Douching and harsh cleansers can actually disrupt your natural microbiome, increasing the risk of infection and shifting your CST to a less healthy state. Gentle, unscented hygiene is best22.

Myth 4: “Once you have a CST, it never changes.”

Fact: CSTs can fluctuate due to menstruation, sexual activity, antibiotics, hormonal changes, pregnancy, and menopause. Your vaginal microbiome is dynamic, not static23. Common causes for CST changes include:

  • Antibiotic use: Antibiotics don’t just kill infection-causing bacteria; they can also kill the healthy bacteria that are currently dominating your vaginal microbiome and defining your CST24.
  • During Pregnancy: Hormonal changes can affect your vaginal microbiome. It’s important to understand how your CST changes during pregnancy, as certain CSTs can put you at risk of preterm birth.
  • Menopause: Lower estrogen levels can lead to lower levels of vaginal lactobacilli, shifting your CST. 

How to Find Out Your CST: Step-by-Step

Information is power, especially when it comes to your vaginal health. Especially if you’ve struggled with uncomfortable symptoms and recurrent vaginal infections, learning your CST type can be the first step to finally finding comfort.

1. Choose a Testing Method

  • Clinical Testing: Some gynecologists and clinics offer vaginal microbiome testing, often using 16S rRNA gene sequencing25.
  • At-Home Test Kits: Several reputable companies provide mail-in kits. You’ll collect a vaginal swab sample in the privacy of your home.

2. Collect Your Sample

  • If using an at-home test, follow the instructions carefully to ensure an accurate result. This usually means using a sterile swab and avoiding douching or sexual activity for 24 hours before sampling.

3. Send in Your Sample (At-Home Testing)

  • Mail your sample to the lab using the provided packaging. Turnaround is typically 1–3 weeks.

4. Review Your Results

  • Your report will show your dominant bacteria and CST type (I–V, with possible subtypes). It may also highlight your vaginal pH and the presence of any potentially disruptive microbes.

5. Consult Your Healthcare Provider

  • If you received your CST report through at-home or mail-in testing, bring your results to your provider for interpretation, especially if you have symptoms or concerns. They can help you understand what your CST means for your health and next steps.

Personalized Recommendations Based on Your CST

When you bring or review your CST results with your healthcare provider, they will be able to offer personalized recommendations to improve or maintain your vaginal health. These often include:

For CST I, II, or V (Lactobacillus-Dominated): Maintain the Balance

  • Continue healthy habits, like a balanced diet, gentle hygiene, and limited antibiotic use.
  • Consider a daily probiotic supplement with well-studied Lactobacillus strains (like L. crispatus or L. rhamnosus) to reinforce your defenses26.
  • Monitor for changes. Though you are in a protective state now, CST can change, and your body will typically let you know when something is off.

If You Have CST III (Lactobacillus iners-Dominated): Support Stability

  • L. iners can coexist with both helpful and disruptive bacteria, so your microbiome may be more prone to shifts.
  • Focus on stress management, a fiber-rich diet, and avoiding unnecessary vaginal products.
  • Probiotics may help, but results can vary. Look for vaginal health probiotics that contain clinically studied strains, like Happy V, and discuss them with your provider before starting.

If You Have CST IV (Low-Lactobacillus, High Diversity): Be Proactive

  • This CST is linked to higher pH, BV risk, and inflammation. If you aren’t experiencing symptoms now, without changes to your routine, you could experience them in the future27.
  • If you’re pregnant, planning pregnancy, or have recurrent symptoms, regular monitoring is especially important.
  • Avoid douching and harsh cleansers, which can make things worse.
    Talk to your provider about targeted probiotics or other interventions.

How Happy V Probiotics Can Help

If you're dealing with vaginal discomfort, recurring infections, or have a less-stable CST type, probiotics can be a powerful part of your toolkit.

Happy V’s Prebiotic + Probiotic is doctor-formulated and contains only clinically studied probiotic strains like Lactobacillus rhamnosus and L. acidophilus, chosen for their ability to produce lactic acid and reduce overgrowth of microbes like Candida albicans and Gardnerella vaginalis.

Preclinical studies suggest that these strains support a shift from CST IV to more protective, Lactobacillus-dominated CSTs. They don’t treat active infections, but they can help you maintain microbial balance, especially if your CST keeps swinging in the wrong direction.

When Should You See a Healthcare Provider?

It’s important to remember that every woman’s vaginal microbiome is unique, and occasional changes in discharge, odor, or comfort are common. However, you should contact your healthcare provider if you experience any of the following:

  • Persistent or strong vaginal odor
  • Unusual or excessive discharge (especially if it changes color or consistency)
  • Itching, burning, or irritation that doesn’t go away
  • Pain during sex or urination
  • Unexpected vaginal bleeding

These symptoms may indicate an imbalance in your microbiome or another health issue that requires professional assessment.

If you’re curious about your CST, experiencing recurrent infections, or considering probiotics or microbiome testing, your provider can help you interpret results and recommend the best next steps for your individual needs. Remember: while self-care is important, professional guidance is key for persistent or concerning symptoms.

Final Thoughts

Your vaginal microbiome isn’t just a passive system; it’s a thriving, changing ecosystem influenced by your hormones, habits, and health decisions. Knowing your CST is like reading your microbiome’s mood. And once you know it, you can work with it, not against it.

With education, science, and the right support, you can help your vaginal environment stay resilient, whether you're in CST I or just starting your journey from CST IV.

Keep the Conversation Going

 

Disclaimer: This blog is for informational and educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Statements about supplements have not been evaluated by the Food and Drug Administration. For more information about vaginal infections, visit the CDC or speak to a licensed healthcare provider.

FAQ

What is the healthiest CST?

CST I (Lactobacillus crispatus-dominated) is considered the most protective, but CSTs II and V are also associated with good health.

Can my CST change naturally?

Yes! Life events like menstruation, sex, antibiotics, pregnancy, and menopause can all shift your CST.

Are all women with CST IV unhealthy?

Not at all. Healthy women can have CST IV. Context and symptoms matter most.

How do I test my CST?

Through molecular testing, such as 16S rRNA gene sequencing, available via some clinics and at-home kits.

Can I have more than one CST at once?

You’ll typically have one dominant CST at a time, but your microbiome can shift—sometimes quickly—based on hormones, antibiotics, or other factors.

Is it possible to change my CST permanently?

CSTs can shift with time and support, but “permanent” changes are rare. Think of it as guiding your microbiome toward balance, not locking it in.

Are home remedies safe for shifting my CST?

Some are helpful (like probiotics); others—like douching or garlic—can do more harm than good. Stick with science-backed support.

How often should I test my vaginal microbiome?

Most people benefit from testing once or twice a year, or anytime symptoms or concerns pop up.

Can probiotics help?

Probiotics with well-studied Lactobacillus strains, like Happy V,  may support a healthy vaginal microbiome, but they are not a replacement for professional care if you have symptoms.

[1] PrecisionBiotics. ASTARTE™ & LA-5® – Science Behind the Strains. PrecisionBiotics. Published 2025.

[2] Critchley HOD, Lamb CA, Heinonen PK, et al. Menstruation: Science and Society. Am J Obstet Gynecol. 2020;223(6):863–870. doi:10.1016/j.ajog.2020.06.004.

[3] Critchley HO-D, Babayev E, Bulun S E, Clark S, Garcia-Grau I, Gregersen PK, Kilcoyne A, Kim JJ, Lavender M, Marsh EE, Matteson KA, Maybin JA, Moreno I, Silk K, Sommer M, Simón C, Tariyal R, Taylor HS, Wagner GP, Griffith LG. Menstruation: science and society. American Journal of Obstetrics & Gynecology. 2020 Jul 21;223(5):624–664. doi: 10.1016/j.ajog.2020.06.004.

[4] Romeo M, D’Urso F, Ciccarese G, Di Gaudio F, Broccolo F. Exploring oral and vaginal probiotic solutions for women’s health from puberty to menopause: A narrative review. Microorganisms. 2024;12(8):1614. doi:10.3390/microorganisms12081614.

[5] Menstruation: science and society. Critchley HO-D. Am J Obstet Gynecol. 2020;XXXX(XX):XXX–XXX

[6] Dong W, et al. Characteristics of Vaginal Microbiota of Women Microorganisms. May 2024 ;12(5):1030. doi: 10.3390/microorganisms120510302020 Nov;223(5):624–664. doi: 10.1016/j.ajog.2020.06.004

[7] Amabebe E, Anumba DOC. Psychosocial Stress, Cortisol Levels, and Maintenance of Vaginal Health. Front Immunol. 2018;9:568. doi:10.3389/fendo.2018.00568.

[8] Critchley HD, et al. Colonization and maintenance of microbial populations in the vagina of premenopausal women and the role of community state types in vaginal health and bacterial vaginosis. Menstruation: Science and Society. 2020.

[9] Lyra A, Ala-Jaakkola R, Yeung N, et al. A healthy vaginal microbiota remains stable during oral probiotic supplementation: a randomised, placebo-controlled, triple-blind trial. Clin Microbiol Infect. 2023;29(5):605-613. doi:10.1016/j.cmi.2023.01.023.

[10] Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011 Mar 15;108(Suppl 1):4680–7.

[11] France M, Lehtoranta L, et al. Healthy Vaginal Microbiota and Influence of Probiotics Across the Female Life Span. Front Microbiol. 2022.

[12] Critchley HOD. Menstruation: Science and Society. American Journal of Obstetrics & Gynecology. 2020.

[13] Valeriano VD, et al. Vaginal dysbiosis and the potential of vaginal microbiome-directed therapeutics. Microbiomes. 2024.

[14] Gajer P, Brotman RM, France MT, et al. VALENCIA: a nearest-centroid classification method for vaginal microbial communities based on composition. Microbiome. 2020;8:166. doi:10.1186/s40168-020-00934-6.

[15] Lyra A, Ala-Jaakkola R, Yeung N, et al. A healthy vaginal microbiota remains stable during oral probiotic supplementation: a randomised controlled trial. Microorganisms. 2023;11(2):499. doi:10.3390/microorganisms11020499.

[16] Johnson C. S., Tabrizi S. N., Fairley C. K., et al. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy. Journal of Infectious Diseases. 2006;194(6):828-836. doi:10.1086/506621.

[17] Lehtoranta L, Ala-Jaakkola R, Laitila A, Maukonen J. Healthy Vaginal Microbiota and Influence of Probiotics Across the Female Life Span. Front Microbiol. 2022;13:819958. doi:10.3389/fmicb.2022.819958.

[18] Alberti I. Lactobacilli vaginal colonisation [PDF]. 2015.

[19] Psychosocial Stress, Cortisol Levels, and Maintenance of Vaginal Health – Frontiers.

[20] De Alberti D, Russo R, Terruzzi F, Nobile V, Ouwehand AC. Lactobacilli vaginal colonisation after oral consumption of Respecta® complex: a randomised controlled pilot study. Archives of Gynecology and Obstetrics. 2015;292(4):861-867. doi:10.1007/s00404-015-3711-4.

[21] Amabebe E, Tatiparthy M, Kammala AK, Richardson LS, Taylor BD, Sharma S, Menon R. Vaginal pharmacomicrobiomics modulates risk of persistent and recurrent bacterial vaginosis. npj Biofilms and Microbiomes. 2025;11:115. Published July 1, 2025. doi:10.1038/s41522-025-00748-0.

[22] Villines Z. Home remedies for bacterial vaginosis: Probiotics, garlic, and more. Medical News Today. Updated January 26, 2024.

[23] Chen X, Lu Y, Chen T, Li R. The female vaginal microbiome in health and bacterial vaginosis. Front Cell Infect Microbiol. 2021;11:631972. doi:10.3389/fcimb.2021.631972.

Greenbaum S, Greenbaum G, Moran-Gilad J, Weintraub AY. Ecological dynamics of the vaginal microbiome in relation to health and disease. Am J Obstet Gynecol. 2019;220(4):324-335. doi:10.1016/j.ajog.2018.11.1089.

[24] Abbe C, Mitchell CM. Bacterial vaginosis: a review of approaches to treatment and prevention. Front Reprod Health. 2023;5:1100029. doi:10.3389/frph.2023.1100029.

[25] Critchley HOD, Kelly RW, Brenner RM, et al. Current findings in endometrial microbiome: impact on uterine diseases. Reproduction. 2021;163(5):R1–R13. doi:10.1530/REP-21-0120.

[26] Alberti D, Russo R, Brandsborg E, et al. Lactobacilli vaginal colonisation after oral consumption of Respecta® complex: a randomised controlled pilot study. BMC Infect Dis. 2015;15:255. doi:10.1186/s12879-015-0971-3.

[27] Amabebe E. Vaginal pharmacomicrobiomics modulates risk of persistent and recurrent bacterial vaginosis. npj Biofilms Microbiomes. 2025;11(1):1-13. doi:10.1038/s41522-025-00671-4.

[1] PrecisionBiotics. ASTARTE™ & LA-5® – Science Behind the Strains. PrecisionBiotics. Published 2025.

[2] Critchley HOD, Lamb CA, Heinonen PK, et al. Menstruation: Science and Society. Am J Obstet Gynecol. 2020;223(6):863–870. doi:10.1016/j.ajog.2020.06.004.

[3] Critchley HO-D, Babayev E, Bulun S E, Clark S, Garcia-Grau I, Gregersen PK, Kilcoyne A, Kim JJ, Lavender M, Marsh EE, Matteson KA, Maybin JA, Moreno I, Silk K, Sommer M, Simón C, Tariyal R, Taylor HS, Wagner GP, Griffith LG. Menstruation: science and society. American Journal of Obstetrics & Gynecology. 2020 Jul 21;223(5):624–664. doi: 10.1016/j.ajog.2020.06.004.

[4] Romeo M, D’Urso F, Ciccarese G, Di Gaudio F, Broccolo F. Exploring oral and vaginal probiotic solutions for women’s health from puberty to menopause: A narrative review. Microorganisms. 2024;12(8):1614. doi:10.3390/microorganisms12081614.

[5] Menstruation: science and society. Critchley HO-D. Am J Obstet Gynecol. 2020;XXXX(XX):XXX–XXX

[6] Dong W, et al. Characteristics of Vaginal Microbiota of Women Microorganisms. May 2024 ;12(5):1030. doi: 10.3390/microorganisms120510302020 Nov;223(5):624–664. doi: 10.1016/j.ajog.2020.06.004

[7] Amabebe E, Anumba DOC. Psychosocial Stress, Cortisol Levels, and Maintenance of Vaginal Health. Front Immunol. 2018;9:568. doi:10.3389/fendo.2018.00568.

[8] Critchley HD, et al. Colonization and maintenance of microbial populations in the vagina of premenopausal women and the role of community state types in vaginal health and bacterial vaginosis. Menstruation: Science and Society. 2020.

[9] Lyra A, Ala-Jaakkola R, Yeung N, et al. A healthy vaginal microbiota remains stable during oral probiotic supplementation: a randomised, placebo-controlled, triple-blind trial. Clin Microbiol Infect. 2023;29(5):605-613. doi:10.1016/j.cmi.2023.01.023.

[10] Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011 Mar 15;108(Suppl 1):4680–7.

[11] France M, Lehtoranta L, et al. Healthy Vaginal Microbiota and Influence of Probiotics Across the Female Life Span. Front Microbiol. 2022.

[12] Critchley HOD. Menstruation: Science and Society. American Journal of Obstetrics & Gynecology. 2020.

[13] Valeriano VD, et al. Vaginal dysbiosis and the potential of vaginal microbiome-directed therapeutics. Microbiomes. 2024.

[14] Gajer P, Brotman RM, France MT, et al. VALENCIA: a nearest-centroid classification method for vaginal microbial communities based on composition. Microbiome. 2020;8:166. doi:10.1186/s40168-020-00934-6.

[15] Lyra A, Ala-Jaakkola R, Yeung N, et al. A healthy vaginal microbiota remains stable during oral probiotic supplementation: a randomised controlled trial. Microorganisms. 2023;11(2):499. doi:10.3390/microorganisms11020499.

[16] Johnson C. S., Tabrizi S. N., Fairley C. K., et al. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy. Journal of Infectious Diseases. 2006;194(6):828-836. doi:10.1086/506621.

[17] Lehtoranta L, Ala-Jaakkola R, Laitila A, Maukonen J. Healthy Vaginal Microbiota and Influence of Probiotics Across the Female Life Span. Front Microbiol. 2022;13:819958. doi:10.3389/fmicb.2022.819958.

[18] Alberti I. Lactobacilli vaginal colonisation [PDF]. 2015.

[19] Psychosocial Stress, Cortisol Levels, and Maintenance of Vaginal Health – Frontiers.

[20] De Alberti D, Russo R, Terruzzi F, Nobile V, Ouwehand AC. Lactobacilli vaginal colonisation after oral consumption of Respecta® complex: a randomised controlled pilot study. Archives of Gynecology and Obstetrics. 2015;292(4):861-867. doi:10.1007/s00404-015-3711-4.

[21] Amabebe E, Tatiparthy M, Kammala AK, Richardson LS, Taylor BD, Sharma S, Menon R. Vaginal pharmacomicrobiomics modulates risk of persistent and recurrent bacterial vaginosis. npj Biofilms and Microbiomes. 2025;11:115. Published July 1, 2025. doi:10.1038/s41522-025-00748-0.

[22] Villines Z. Home remedies for bacterial vaginosis: Probiotics, garlic, and more. Medical News Today. Updated January 26, 2024.

[23] Chen X, Lu Y, Chen T, Li R. The female vaginal microbiome in health and bacterial vaginosis. Front Cell Infect Microbiol. 2021;11:631972. doi:10.3389/fcimb.2021.631972.

Greenbaum S, Greenbaum G, Moran-Gilad J, Weintraub AY. Ecological dynamics of the vaginal microbiome in relation to health and disease. Am J Obstet Gynecol. 2019;220(4):324-335. doi:10.1016/j.ajog.2018.11.1089.

[24] Abbe C, Mitchell CM. Bacterial vaginosis: a review of approaches to treatment and prevention. Front Reprod Health. 2023;5:1100029. doi:10.3389/frph.2023.1100029.

[25] Critchley HOD, Kelly RW, Brenner RM, et al. Current findings in endometrial microbiome: impact on uterine diseases. Reproduction. 2021;163(5):R1–R13. doi:10.1530/REP-21-0120.

[26] Alberti D, Russo R, Brandsborg E, et al. Lactobacilli vaginal colonisation after oral consumption of Respecta® complex: a randomised controlled pilot study. BMC Infect Dis. 2015;15:255. doi:10.1186/s12879-015-0971-3.

[27] Amabebe E. Vaginal pharmacomicrobiomics modulates risk of persistent and recurrent bacterial vaginosis. npj Biofilms Microbiomes. 2025;11(1):1-13. doi:10.1038/s41522-025-00671-4.